{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:03:18Z","timestamp":1793120598364,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The future of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic hinges on virus evolution and duration of immune protection of natural infection against reinfection. We investigated the duration of protection afforded by natural infection, the effect of viral immune evasion on duration of protection and protection against severe reinfection, in Qatar, between 28 February 2020 and 5 June 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three national, matched, retrospective cohort studies were conducted to compare the incidence of SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) severity among unvaccinated persons with a documented SARS-CoV-2 primary infection, to incidence among those infection-na\u00efve and unvaccinated. Associations were estimated using Cox proportional hazard regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Effectiveness of pre-Omicron primary infection against pre-Omicron reinfection was 85.5% [95% confidence interval (CI): 84.8\u201386.2%]. Effectiveness peaked at 90.5% (95% CI: 88.4\u201392.3%) in the 7th month after the primary infection, but waned to ~\u200970% by the 16th month. Extrapolating this waning trend using a Gompertz curve suggested an effectiveness of 50% in the 22nd month and\u2009&amp;lt;\u200910% by the 32nd month. Effectiveness of pre-Omicron primary infection against Omicron reinfection was 38.1% (95% CI: 36.3\u201339.8%) and declined with time since primary infection. A Gompertz curve suggested an effectiveness of &amp;lt;\u200910% by the 15th month. Effectiveness of primary infection against severe, critical or fatal COVID-19 reinfection was 97.3% (95% CI: 94.9\u201398.6%), irrespective of the variant of primary infection or reinfection, and with no evidence for waning. Similar results were found in sub-group analyses for those \u226550\u00a0years of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Protection of natural infection against reinfection wanes and may diminish within a few years. Viral immune evasion accelerates this waning. Protection against severe reinfection remains very strong, with no evidence for waning, irrespective of variant, for over 14\u00a0months after primary infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jtm\/taac109","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T17:11:12Z","timestamp":1663866672000},"source":"Crossref","is-referenced-by-count":94,"title":["Duration of immune protection of SARS-CoV-2 natural infection against reinfection"],"prefix":"10.1093","volume":"29","author":[{"given":"Hiam","family":"Chemaitelly","sequence":"first","affiliation":[{"name":"Infectious Disease Epidemiology Group, Research Department, Weill Cornell Medicine-Qatar, Cornell University , Doha, Qatar"},{"name":"World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV\/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine\u2013Qatar, Cornell University, Qatar Foundation \u2013 Education City , Doha, Qatar"},{"name":"Department of Population Health Sciences, Weill Cornell Medicine, Cornell University , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Nagelkerke","sequence":"additional","affiliation":[{"name":"Infectious Disease Epidemiology Group, Research Department, Weill Cornell Medicine-Qatar, Cornell University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssein H","family":"Ayoub","sequence":"additional","affiliation":[{"name":"Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Coyle","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"},{"name":"Biomedical Research Center, QU Health, Qatar University , Doha, Qatar"},{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queens University , Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sidra Medicine , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi M","family":"Yassine","sequence":"additional","affiliation":[{"name":"Biomedical Research Center, QU Health, Qatar University , Doha, Qatar"},{"name":"Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebah A","family":"Al-Khatib","sequence":"additional","affiliation":[{"name":"Biomedical Research Center, QU Health, Qatar University , Doha, Qatar"},{"name":"Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K","family":"Smatti","sequence":"additional","affiliation":[{"name":"Biomedical Research Center, QU Health, Qatar University , Doha, Qatar"},{"name":"Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sidra Medicine , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Al-Kanaani","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einas","family":"Al-Kuwari","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jeremijenko","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvar Hassan","family":"Kaleeckal","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Nizar","family":"Latif","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyazuddin Mohammad","family":"Shaik","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan F","family":"Abdul-Rahim","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Health Sciences, QU Health, Qatar University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheyath K","family":"Nasrallah","sequence":"additional","affiliation":[{"name":"Biomedical Research Center, QU Health, Qatar University , Doha, Qatar"},{"name":"Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ghaith","family":"Al-Kuwari","sequence":"additional","affiliation":[{"name":"Primary Health Care Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-1826","authenticated-orcid":false,"given":"Adeel A","family":"Butt","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine, Cornell University , New York, NY, USA"},{"name":"Hamad Medical Corporation , Doha, Qatar"},{"name":"Department of Medicine, Weill Cornell Medicine, Cornell University ,New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad Eid","family":"Al-Romaihi","sequence":"additional","affiliation":[{"name":"Ministry of Public Health , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H","family":"Al-Thani","sequence":"additional","affiliation":[{"name":"Ministry of Public Health , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Al-Khal","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bertollini","sequence":"additional","affiliation":[{"name":"Ministry of Public Health , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-0506","authenticated-orcid":false,"given":"Laith J","family":"Abu-Raddad","sequence":"additional","affiliation":[{"name":"Infectious Disease Epidemiology Group, Research Department, Weill Cornell Medicine-Qatar, Cornell University , Doha, Qatar"},{"name":"World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV\/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine\u2013Qatar, Cornell University, Qatar Foundation \u2013 Education City , Doha, Qatar"},{"name":"Department of Population Health Sciences, Weill Cornell Medicine, Cornell University , New York, NY, USA"},{"name":"Department of Public Health, College of Health Sciences, QU Health, Qatar University , Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"2022122710512705500_ref1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41591-022-01836-w","article-title":"An early warning system for emerging SARS-CoV-2 variants","volume":"28","author":"Subissi","year":"2022","journal-title":"Nat Med"},{"key":"2022122710512705500_ref2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.abe6522","article-title":"Immunological characteristics govern the transition of COVID-19 to endemicity","volume":"371","author":"Lavine","year":"2021","journal-title":"Science"},{"key":"2022122710512705500_ref3","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMc2108120","article-title":"Severity of SARS-CoV-2 reinfections as compared with primary infections","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref5","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"2022122710512705500_ref7","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/s41467-022-30895-3","article-title":"Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar","volume":"13","author":"Chemaitelly","year":"2022","journal-title":"Nat Commun"},{"key":"2022122710512705500_ref8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1473-3099(22)00409-1","article-title":"Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant","volume":"22","author":"Higdon","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2022122710512705500_ref9","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","article-title":"The eradication of smallpox \u2013 an overview of the past, present, and future","volume":"29","author":"Henderson","year":"2011","journal-title":"Vaccine"},{"key":"2022122710512705500_ref10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.abb5793","article-title":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period","volume":"368","author":"Kissler","year":"2020","journal-title":"Science"},{"key":"2022122710512705500_ref11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100861","article-title":"SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy","volume":"35","author":"Abu-Raddad","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2022122710512705500_ref12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/01632787211047932","article-title":"A systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection","volume":"44","author":"Kojima","year":"2021","journal-title":"Eval Health Prof"},{"key":"2022122710512705500_ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112911","article-title":"SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity","volume":"209","author":"Pilz","year":"2022","journal-title":"Environ Res"},{"key":"2022122710512705500_ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003879","article-title":"Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: a nationally representative cohort study","volume":"18","author":"Abu-Raddad","year":"2021","journal-title":"PLoS Med"},{"key":"2022122710512705500_ref15","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1056\/NEJMc2110300","article-title":"Efficacy of natural immunity against SARS-CoV-2 reinfection with the beta variant","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the Omicron variant from previous SARS-CoV-2 infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of previous infection and vaccination on symptomatic Omicron infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref18","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/s41467-022-32363-4","article-title":"Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage","volume":"13","author":"Chemaitelly","year":"2022","journal-title":"Nat Commun"},{"key":"2022122710512705500_ref19","doi-asserted-by":"crossref","article-title":"Protection of SARS-CoV-2 natural infection against reinfection with the Omicron BA.4 or BA.5 subvariants","author":"Altarawneh","DOI":"10.1101\/2022.07.11.22277448"},{"key":"2022122710512705500_ref20","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1038\/s41598-021-85428-7","article-title":"Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic","volume":"11","author":"Abu-Raddad","year":"2021","journal-title":"Sci Rep"},{"key":"2022122710512705500_ref21","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMoa2200797","article-title":"Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hernan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"2022122710512705500_ref23","volume-title":"COVID-19 clinical management: living guidance","author":"World Health Organization","year":"2021"},{"key":"2022122710512705500_ref24","volume-title":"International guidelines for certification and classification (coding) of COVID-19 as cause of death","author":"World Health Organization"},{"key":"2022122710512705500_ref25","doi-asserted-by":"crossref","first-page":"05005","DOI":"10.7189\/jogh.11.05005","article-title":"Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19","volume":"11","author":"Ayoub","year":"2021","journal-title":"J Glob Health"},{"key":"2022122710512705500_ref26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102646","article-title":"SARS-CoV-2 seroprevalence in the urban population of Qatar: an analysis of antibody testing on a sample of 112,941 individuals","volume":"24","author":"Coyle","year":"2021","journal-title":"iScience"},{"key":"2022122710512705500_ref27","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab221","article-title":"SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar","volume":"8","author":"Al-Thani","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2022122710512705500_ref28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3201\/eid2705.204365","article-title":"Herd immunity against severe acute respiratory syndrome coronavirus 2 infection in 10 communities, Qatar","volume":"27","author":"Jeremijenko","year":"2021","journal-title":"Qatar Emerg Infect Dis"},{"key":"2022122710512705500_ref29","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab083","article-title":"Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses","volume":"28","author":"Abu-Raddad","year":"2021","journal-title":"J Travel Med"},{"key":"2022122710512705500_ref30","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41591-021-01446-y","article-title":"mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar","volume":"27","author":"Chemaitelly","year":"2021","journal-title":"Nat Med"},{"key":"2022122710512705500_ref31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMc2119432","article-title":"Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMc2117933","article-title":"Effectiveness of mRNA-1273 and BNT162b2 vaccines in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref33","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"2022122710512705500_ref34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat"},{"key":"2022122710512705500_ref35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2022122710512705500_ref36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/01.ede.0000229196.41862.c2","article-title":"Still protected against smallpox? Estimation of the duration of vaccine-induced immunity against smallpox","volume":"17","author":"Nishiura","year":"2006","journal-title":"Epidemiology"},{"key":"2022122710512705500_ref37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijid.2021.09.006","article-title":"Real-time SARS-CoV-2 genotyping by high-throughput multiplex PCR reveals the epidemiology of the variants of concern in Qatar","volume":"112","author":"Hasan","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2022122710512705500_ref38","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.768883","article-title":"One Year of SARS-CoV-2: genomic characterization of COVID-19 outbreak in Qatar","volume":"11","author":"Benslimane","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2022122710512705500_ref39","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJMc070348","article-title":"Disappearance of antibodies to SARS-associated coronavirus after recovery","volume":"357","author":"Cao","year":"2007","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.201410-1798OC","article-title":"Longevity and determinants of protective humoral immunity after pandemic influenza infection","volume":"191","author":"Sridhar","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2022122710512705500_ref41","doi-asserted-by":"crossref","article-title":"Effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection among children and adolescents in Qatar","author":"Chemaitelly","DOI":"10.1101\/2022.07.26.22278045"},{"key":"2022122710512705500_ref42","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S2666-5247(21)00180-4","article-title":"Immune-mediated attenuation of influenza illness after infection: opportunities and challenges","volume":"2","author":"Patel","year":"2021","journal-title":"Lancet Microbe"},{"key":"2022122710512705500_ref43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/cid\/ciz706","article-title":"Depletion-of-susceptibles bias in analyses of intra-season waning of influenza vaccine effectiveness","volume":"70","author":"Ray","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022122710512705500_ref44","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.2021.19623","article-title":"Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar","volume":"326","author":"Abu-Raddad","year":"2021","journal-title":"JAMA"},{"key":"2022122710512705500_ref45","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac068","article-title":"Effects of BA.1\/BA.2 subvariant, vaccination, and prior infection on infectiousness of SARS-CoV-2 omicron infections","volume":"29","author":"Qassim","year":"2022","journal-title":"J Travel Med"},{"key":"2022122710512705500_ref46","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab190","article-title":"Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in na\u00efve and previously infected individuals","volume":"28","author":"Al-Sadeq","year":"2021","journal-title":"J Travel Med"},{"key":"2022122710512705500_ref47","doi-asserted-by":"crossref","first-page":"18182","DOI":"10.1038\/s41598-021-97606-8","article-title":"SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar","volume":"11","author":"Seedat","year":"2021","journal-title":"Sci Rep"},{"key":"2022122710512705500_ref48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2104974","article-title":"Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 Variants","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N Engl J Med"},{"key":"2022122710512705500_ref49","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taac109\/46671704\/taac109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/29\/8\/taac109\/48419852\/taac109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/29\/8\/taac109\/48419852\/taac109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T05:53:09Z","timestamp":1672120389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taac109\/6731972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,9,30]]},"published-print":{"date-parts":[[2022,12,27]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taac109","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.06.22277306","asserted-by":"object"}]},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,9,30]]},"article-number":"taac109"}}